Clinical Trials Browser

Recurrence × Irinotecan × 30 days × Clear all

NCT04619056 2026-05-12

First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma

Phase 1 Completed

Recurrence, Sarcoma